ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$2.64 USD
-0.12 (-4.35%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.63 -0.01 (-0.38%) 6:12 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
ADC Therapeutics SA's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADCT 2.64 -0.12(-4.35%)
Will ADCT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADCT
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
ADCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zymeworks Inc. (ZYME) Reports Q1 Loss, Tops Revenue Estimates
Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates
AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates
Other News for ADCT
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, ...
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan | ADCT Stock News
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan | ADCT Stock News
ADC Therapeutics (ADCT) Files Prospectus for Share Sale
ADC Therapeutics files to sell 27.73M common shares by selling shareholders